0001179110-20-008623.txt : 20200731
0001179110-20-008623.hdr.sgml : 20200731
20200731165936
ACCESSION NUMBER: 0001179110-20-008623
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200729
FILED AS OF DATE: 20200731
DATE AS OF CHANGE: 20200731
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marshall Randall
CENTRAL INDEX KEY: 0001799325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36694
FILM NUMBER: 201066712
MAIL ADDRESS:
STREET 1: C/O ARTARA THERAPEUTICS, INC.
STREET 2: 1 LITTLE WEST 12TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001359931
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 204580525
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 LITTLE WEST 12TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 646-844-0337
MAIL ADDRESS:
STREET 1: 1 LITTLE WEST 12TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: ArTara Therapeutics, Inc.
DATE OF NAME CHANGE: 20200110
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEON THERAPEUTICS INC
DATE OF NAME CHANGE: 20060420
4
1
edgar.xml
FORM 4 -
X0306
4
2020-07-29
0
0001359931
Protara Therapeutics, Inc.
TARA
0001799325
Marshall Randall
6 CURVE STREET
SHERBORN
MA
01770
0
0
1
0
Common Stock
2020-07-29
4
S
0
1816
26.03
D
613197
D
Common Stock
2020-07-29
4
S
0
600
27.28
D
612597
D
Common Stock
2020-07-29
4
S
0
100
28.45
D
612497
D
Common Stock
2020-07-30
4
S
0
1317
26.14
D
611180
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.35, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.02 to $27.83, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.525, inclusive.
John D. Chambliss, as Attorney-in-Fact
2020-07-31